Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus

Gudula Kirtschig, K. H. Becker, Andreas R. Günthert, Daiva Jasaitienė, Susan M. Cooper, Alexander Kreuter, Katharina Rall, Werner Aberer, Silke Riechardt, Francesco Casabona,

Journal of the European Academy of Dermatology and Venereology · 2015 · 343 citations · 202 references

DOIFull text

Open access

Concepts

Abstract

Lichen sclerosus (LS) is an inflammatory skin disease that usually involves the anogenital area. All patients with symptoms or signs suspicious of lichen sclerosus should be seen at least once initially by a physician with a special interest in the disease in order to avoid delay in diagnosis, as early treatment may cure the disease in some and reduce or prevent scarring. The diagnosis is made clinically in most cases. Biopsies should only be performed under certain circumstances. The gold standard for treatment remains potent to very potent topical steroids; however, mild and moderate disease in boys and men may be cured by circumcision. Certain triggers should be avoided. http://www.euroderm.org/images/stories/guidelines/2014/S3-Guideline-on-Lichen-sclerosus.pdf http://www.awmf.org/fachgesellschaften/mitgliedsgesellschaften/visitenkarte/fg/deutsche-gesellschaft-fuer-gynaekologie-und-geburtshilfe-dggg.html.

References

202